Anti-Infective Pharmaceuticals Market in India 2012

Date: April 6, 2012
Pages: 82
Price:
US$ 795.00
Publisher: Netscribes (India) Pvt. Ltd.
Report type: Brief Review
Delivery: E-mail Delivery (PDF)
ID: A50EA202A16EN
Leaflet:

Download PDF Leaflet

Anti-Infective Pharmaceuticals Market in India 2012
Anti-infective pharmaceuticals market in India is the largest contributor to domestic pharmaceutical sales, contributing around 18%. Since India has a huge patient pool, the Indian market is characterized by a huge demand for anti-infective drugs. It is a highly fragmented market with a large number of foreign and domestic players. The huge increase in the patient population, increasing number of vaccine approvals, increase in health insurances and introduction of newer and better drugs is helping the market to grow. The Indian Government, on its part, has introduced some control programmes, undertaken various Private Partnership Projects (PPP) and has taken initiatives to reduce drug prices. The market is expected to exhibit steady growth over the next few years.

The report begins with the introduction section which offers a brief classification of the anti infectives market. It then moves to the market overview section which provides an insight into the global market and then moves on to the Indian market, highlighting the market size and growth.

An analysis of the drivers explains the factors for growth of the industry including increasing patient population, increasing vaccine approvals, increase in health insurances and introduction of newer and better drugs. The key challenges include pricing pressure and logistic problems in the vaccine market.

The government initiatives section gives a brief description of the different control programmes undertaken by the Government. It also analyses the efforts to reduce drug prices, changes in the customs duty structure and the various PPP projects undertaken by the Government.

A brief overview of the drug regulations and patents is presented in the next section. It focuses the different stages of clinical trial that a drug must pass through. Drug regulations in India and drugs approved for marketing have been provided. The section also provides a list of important patent approvals for anti infective drugs.

The competition section gives overview of pharmaceutical companies in the country operating in the anti diabetic pharmaceutical and insulin segments. Thereafter, the report highlights the features of the major players operating in the market in detail. It includes elaborate profile of the major players in the market along with their financial analysis. Porters Five Forces Analysis has been incorporated for a brief but effective understanding of the market scenario. It also incorporates the recent developments in the Anti Infective Pharmaceutical industry.

The strategic recommendations section focuses on some effective strategic decisions which can be taken up by companies to increase their market shares. Foray into the production of adult vaccines and improvement in the logistics of the vaccine market will help the companies increase their customer base. Also, efficient marketing strategies, like strategic alliances of foreign companies with local manufacturers, or tie-ups of domestic manufacturers with Government bodies and non-governmental organizations will increase the profitability of the companies.
Page 1: Executive summary

INTRODUCTION

Page 2: Classification of anti infective pharmaceutical market
Page 3: Types of anti infective drugs

MARKET OVERVIEW

Page 4: Global Anti-Infective Pharmaceuticals Market – Overview, Size & Growth (Value: 2010-15e),
Page 5: Indian Anti-Infective Pharmaceuticals Market- Overview, Size & Growth (Value: 2010-2015e), Growth in Therapeutic segments

DRIVERS & CHALLENGES

Page 6: Summary
Page 7-10: Drivers
Page 11: Challenges

GOVERNMENT INITIATIVES

Page 12: Summary
Page 13-20: Government Initiatives

MARKET VALUE CHAIN, REGULATION AND PATENTS

Page 21: Pharmaceutical value chain
Page 22: Phases of clinical trials
Page 23-24: Drug regulations
Page 25: Regulatory framework
Page 26-28: List of patent approvals

COMPETITION

Page 29: Market Competition – Porter’s Five Forces Analysis
Page 30- 71: Major Public Companies
  Abbott India Limited
  Cipla Limited
  Claris Lifesciences Limited
  GlaxoSmithKline Pharmaceuticals Limited
  Glenmark Pharmaceuticals Limited
  Lupin Limited
  Novartis India Limited
  Panacea Biotec Limited
  Pfizer Limited
  Ranbaxy Laboratories Limited
  Sun Pharmaceutical Industries Limited
  Torrent Pharmaceuticals Limited
  Wockhardt Limited
  Gilead Sciences Inc.
Page 72- 80: Major Private Companies
  Bristol-Myers Squibb India Private Limited
  Takeda Pharmaceuticals India Private Limited
  Watson Pharma Private Limited
Page 81: Recent Developments

STRATEGIC RECOMMENDATION

Page 82: Strategic Recommendations
Skip to top


Anti-Infectives: Market Research Report US$ 3,950.00 Feb, 2010 · 825 pages
Anti-Diabetic Pharmaceuticals Market in India 2015 US$ 1,050.00 Jul, 2015 · 74 pages
Competitor Analysis: Anti-Infective Antibodies US$ 1,086.00 Nov, 2011 · 160 pages
Competitor Analysis: Anti-Infective Peptides US$ 446.00 Oct, 2014 · 68 pages
OTC Pharmaceuticals in India US$ 350.00 Sep, 2016 · 39 pages

Ask Your Question

Anti-Infective Pharmaceuticals Market in India 2012
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: